Reality check: testing the in silico predictions of false negative results due to mutations in SARS-CoV-2 PCR assays using templates with mismatches in vitro
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1524025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Taylor Otwell und 7 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Health Surveillance and Diagnostics, MRIGlobal, Kansas City, MO, United States. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Mutation, COVID-19 Nucleic Acid Testing. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Molecular diagnostic assays are critical tools to test, diagnose and treat infectious and other diseases. For example, PCR test results have been extremely valuable during the COVID-19 pandemic, not only to provide appropriate health care for infected and symptomatic individuals as needed, but also for implementing public health measures such as test, trace and isolate infected and asymptomatic individuals to prevent further transmission of the virus. Sustained transmission and unhindered proliferation of the pathogen across the population during a continuous, ongoing pandemic such as COVID-19, resulted in many variants with mutations. These mutations may lead to signature erosion, a phenomenon wherein diagnostic tests developed using the genomic sequence of an earlier version of the pathogen, may fail and cause a false negative (FN) result in a sample containing a new variant. We and others have developed applications such as PSET (PCR Signature Erosion Tool) to monitor the performance of diagnostic tests in silico using pathogen genomic sequences. Here, we present and discuss the data on wet lab testing of the in silico predictions to assess assay performance with mismatches in assay signatures. We found that the majority of the assays performed without drastic reduction in assay performance even with mismatches in primer and probe regions as measured by PCR efficiencies and C t value shifts. We identified critical residues and positions and types of changes that may impact assay performance. Despite the extensive accumulation of mutations in SARS-CoV-2 variants over the course of the various waves of the pandemic, most PCR assays proved to be extremely robust and continued to perform well even with drastic changes and signature erosion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Integrated Health Surveillance and Diagnostics, MRIGlobal, Kansas City, MO, United States.
- Laboratory of Mucosal Pathogens & Cellular Immunology, Division of Bacterial, Parasitic and Allergenic Products, Office of Vaccines Research and Review, Biologics Evaluation and Research, U.S. Food and Drug Administrati…
- National Strategic Research Institute, Nebraska Medical Center, Omaha, NE, United States.
- Defense Biological Product Assurance Office (DBPAO), Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), Enabling Biotechnologies, Frederick, MD, United States.
- Joint Research and Development, LLC, Stafford, VA, United States.
Zitieren
APA
Otwell, T., Knight, B., Coryell, M., Stone, J., Davis, P., Necciai, B., Carlson, P., & Sozhamannan, S. (2025). Reality check: testing the in silico predictions of false negative results due to mutations in SARS-CoV-2 PCR assays using templates with mismatches in vitro. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1524025
Vancouver
Otwell T, Knight B, Coryell M, Stone J, Davis P, Necciai B, et al. Reality check: testing the in silico predictions of false negative results due to mutations in SARS-CoV-2 PCR assays using templates with mismatches in vitro. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1524025
BibTeX
@article{Otwell2025,
author = {Otwell, Taylor and Knight, Brittany and Coryell, Michael and Stone, Jennifer and Davis, Phillip and Necciai, Bryan and Carlson, Paul and Sozhamannan, Shanmuga},
title = {Reality check: testing the in silico predictions of false negative results due to mutations in SARS-CoV-2 PCR assays using templates with mismatches in vitro},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1524025}
}
EUVIMED